These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24919708)

  • 1. Radiation exposure of patients undergoing whole-body FDG-PET/CT examinations: an update pursuant to the new ICRP recommendations.
    Brix G; Nosske D; Lechel U
    Nuklearmedizin; 2014; 53(5):217-20. PubMed ID: 24919708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.
    Brix G; Lechel U; Glatting G; Ziegler SI; Münzing W; Müller SP; Beyer T
    J Nucl Med; 2005 Apr; 46(4):608-13. PubMed ID: 15809483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations.
    Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS
    J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
    Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
    Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JOURNAL CLUB: CT dose optimization for whole-body PET/CT examinations.
    Tonkopi E; Ross AA; MacDonald A
    AJR Am J Roentgenol; 2013 Aug; 201(2):257-63. PubMed ID: 23883207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technologist radiation exposure in routine clinical practice with 18F-FDG PET.
    Guillet B; Quentin P; Waultier S; Bourrelly M; Pisano P; Mundler O
    J Nucl Med Technol; 2005 Sep; 33(3):175-9. PubMed ID: 16145226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.
    Rausch I; Bergmann H; Geist B; Schaffarich M; Hirtl A; Hacker M; Beyer T
    Nuklearmedizin; 2014; 53(6):242-8. PubMed ID: 25131649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG.
    Leide-Svegborn S
    Radiat Prot Dosimetry; 2010; 139(1-3):208-13. PubMed ID: 20167792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods of CT Dose Estimation in Whole-Body ¹⁸F-FDG PET/CT.
    Inoue Y; Nagahara K; Tanaka Y; Miyatake H; Hata H; Hara T
    J Nucl Med; 2015 May; 56(5):695-700. PubMed ID: 25840979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT.
    Willowson KP; Bailey EA; Bailey DL
    Australas Phys Eng Sci Med; 2012 Mar; 35(1):49-53. PubMed ID: 22160927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
    Liu D; Khong PL; Gao Y; Mahmood U; Quinn B; St Germain J; Xu XG; Dauer LT
    J Nucl Med; 2016 Jun; 57(6):907-12. PubMed ID: 26823568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
    J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
    Quinn B; Dauer Z; Pandit-Taskar N; Schoder H; Dauer LT
    BMC Med Imaging; 2016 Jun; 16(1):41. PubMed ID: 27317478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body 18F-FDG PET/CT: the need for a standardized field of view--a referring-physician aid.
    Huston SF; Abdelmalik AG; Nguyen NC; Farghaly HR; Osman MM
    J Nucl Med Technol; 2010 Sep; 38(3):123-7. PubMed ID: 20724533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determination of patient dose from (18)F-FDG PET/CT examination.
    Khamwan K; Krisanachinda A; Pasawang P
    Radiat Prot Dosimetry; 2010 Sep; 141(1):50-5. PubMed ID: 20400773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011.
    Etard C; Celier D; Roch P; Aubert B
    Radiat Prot Dosimetry; 2012 Dec; 152(4):334-8. PubMed ID: 22586156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body PET/CT studies with lowered ¹⁸F-FDG doses: the influence of body mass index in dose reduction.
    Sánchez-Jurado R; Devis M; Sanz R; Aguilar JE; del Puig Cózar M; Ferrer-Rebolleda J
    J Nucl Med Technol; 2014 Mar; 42(1):62-7. PubMed ID: 24503348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Australian local diagnostic reference level for paediatric whole-body
    Alkhybari EM; McEntee MF; Willowson KP; Brennan PC; Kitsos T; Kench PL
    Br J Radiol; 2019 Apr; 92(1096):20180879. PubMed ID: 30653334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.